Original Article

Long Non-Coding RNA CKMT2-AS1 Reduces the Viability of Colorectal Cancer Cells by Targeting AKT/mTOR Signaling Pathway


Background: Colorectal cancer (CRC) has not only seriously affected people’s lives, but also burdened the government healthcare system. Long non-coding RNAs (lncRNA) have attracted more and more attention in the cancer study field.

Methods: Experiments were completed in the Medical Research and Innovation Center of Shanghai Pudong Hospital, China from 2019 to 2020. Cell cycle was detected by western blot analyzing and flow cytometry. Apoptosis analysis were determined using flow cytometry or western blot analysis. LncRNA CKMT2-AS1 was knocked down by shRNA transfection.

Results: We found CKMT2-AS1 was the most significant=0.0105 for SW480 and P=0.0071 for HCT116) difference lncRNA between colorectal cancer treated with autophagy inducer and colorectal cancer without any treatment. Effective shRNA-CKMT2-AS1 was also designed. Following, we found the treatment of autophagy inducer and autophagy inducer + shRNA-NC were able to suppress the proliferation of both SW480 and HCT116 cells. In addition, the treatment of autophagy inducer + shRNA-CKMT2-AS1 significantly reduced the apoptosis of SW480 and HCT116 cells induced by autophagy. Furthermore, we found the phosphorylation of mTOR, AKT was enhanced in SW480, and HCT116 cells treated with autophagy inducer + shRNA-CKMT2-AS1 compared to the cells treated with autophagy inducer of autophagy inducer + shRNA-NC.

Conclusion: Enhancing the expression of CKMT2-AS1 will become a promising strategy to prevent the progress of colorectal cancer.

1. Siegel R, DeSantis C, Jemal A (2014). Colorectal cancer statistics, 2014. CA Cancer J Clin, 64(2):104-17.
2. e Melo FdS, Kurtova AV, Harnoss JM, et al (2017). A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature, 543(7647):676-680.
3. Marley AR, Nan H (2016). Epidemiology of colorectal cancer. Int J Mol Epidemiol Genet, 7(3):105-114.
4. van der Geest LGM, Koopman M, Verhoef C, et al (2015). Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis, 32(5):457-65.
5. Huarte M (2015). The emerging role of lncRNAs in cancer. Nat Med, 21(11):1253-61.
6. Yang G, Lu X, Yuan L (2014). LncRNA: a link between RNA and cancer. Biochim Biophys Acta, 1839(11):1097-109.
7. Wilusz JE, Sunwoo H, Spector DL (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 23(13):1494-504.
8. Prensner JR, Chinnaiyan AM (2011). The emergence of lncRNAs in cancer biology. Cancer Discov, 1(5):391-407.
9. Chung S, Nakagawa H, Uemura M, et al (2011). Association of a novel long non‐coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci, 102(1):245-52.
10. Gao Y, Meng H, Liu S, et al (2015). LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet, 24(3):841-52.
11. Shi D, Zheng H, Zhuo C, et al (2014). Low expression of novel lncRNA RP11-462C24. 1 suggests a biomarker of poor prognosis in colorectal cancer. Med Oncol, 31(7):31.
12. Han J, Rong LF, Shi CB, et al (2014). Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients. World J Gastroenterol, 20(25):8139-8150.
13. Klionsky DJ (2008). Autophagy revisited: a conversation with Christian de Duve. Autophagy, 4(6):740-3.
14. Mizushima N, Komatsu M (2011). Autophagy: renovation of cells and tissues. Cell, 147(4):728-41.
15. Mathew R, Karantza-Wadsworth V, White E (2007). Role of autophagy in cancer. Nat Rev Cancer, 7(12):961-7.
16. Cheetham SW, Gruhl F, Mattick JS, Dinger ME (2013). Long noncoding RNAs and the genetics of cancer. Br J Cancer, 108(12):2419.
17. Wang S-H, Zhang M-D, Wu X-C, et al (2016). Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion. Tumour Biol, 37(9):12867-75.
18. Porta C, Paglino C, Mosca A (2014). Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol, 4:64.
19. Testa JR, Bellacosa A (2001). AKT plays a central role in tumorigenesis. Proc Natl Acad Sci U S A, 98(20):10983-5.
20. Xu K, Liu P, Wei W (2014). mTOR signaling in tumorigenesis. Biochim Biophys Acta, 1846(2):638-54.
21. Parsons R, Simpson L (2003). PTEN and cancer. Tumor Suppressor Genes: Springer;. p. 147-66.
22. Huang J, Dibble CC, Matsuzaki M, Manning BD (2008). The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Mol Cell Biol, 28(12):4104-15.
23. Li Y, Zeng C, Hu J, et al (2018). Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. J Hematol Oncol, 11(1):89.
24. Luo Y, Ouyang J, Zhou D, et al (2018). Long noncoding RNA GAPLINC promotes cells migration and invasion in colorectal cancer cell by regulating miR-34a/c-MET signal pathway. Dig Dis Sci, 63(4):890-9.
IssueVol 51 No 2 (2022) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v51i2.8685
Colorectal cancer Long non-coding RNAs Gene

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Zhuang B, Ni X, Min Z, Wu D, Wang T, Cui P. Long Non-Coding RNA CKMT2-AS1 Reduces the Viability of Colorectal Cancer Cells by Targeting AKT/mTOR Signaling Pathway. Iran J Public Health. 2022;51(2):327-335.